Development of a New Prognostic Assessment Tool for Postoperative Myocardial Injury
TROPUTILE
1 other identifier
observational
1,600
1 country
2
Brief Summary
Myocardial injury after noncardiac surgery (MINS) is common, silent, and strongly associated with morbi-mortality. There are some evidences in the littérature showing that troponin elevation pre and/or postoperatively and surgical Apgar score are strongly and independently associated with postoperative morbi-mortality. In this cohort study of orthopedic surgery patients (\> 50years), the aim is to determine MINS incidence and to assess wich peri-operative factors are associated with the occurrence of MINS. The final objective is to create a score to better identified the patients with a MINS and a poor outcome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 7, 2020
CompletedFirst Submitted
Initial submission to the registry
February 25, 2020
CompletedFirst Posted
Study publicly available on registry
February 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 7, 2025
CompletedAugust 7, 2024
December 1, 2023
5.3 years
February 25, 2020
August 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative MINS incidence
Troponin elevation \> 5ng/l compared to previous measurement OR troponin elevation \> 65 ng/l
3 days after surgery
Secondary Outcomes (9)
Number of Participants with cardiac arrest
3 months
Number of Participants with an episode of acute pulmonary oedema
3 months
Number of Participants with coronary angioplasty
3 months
Number of Participants with myocardial infarction
3 months
Number of Participants with stroke
3 months
- +4 more secondary outcomes
Eligibility Criteria
Patients aged of 50 years and more, with elective orthopedic surgery in Brest community-affiliated hospital
You may qualify if:
- \> 50 years
- orthopedic surgery (hip, knee, spine)
- written consent
You may not qualify if:
- no troponin measurement prior surgery
- sepsis
- acute coronary syndrome
- pulmonary embolism
- refusing to participate
- guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHRU Brest
Brest, 29200, France
CHU Rennes
Rennes, 35033, France
Study Officials
- PRINCIPAL INVESTIGATOR
Olivier HUET, MD, PhD
CHRU Brest
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 25, 2020
First Posted
February 27, 2020
Study Start
January 7, 2020
Primary Completion
April 7, 2025
Study Completion
April 7, 2025
Last Updated
August 7, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available beginning 21 months and ending five years following the publication
- Access Criteria
- Data access requests will be reviewed by the international committee of Brest UH . Requestors will be required to sign and complete a data acess agreement
All collected data that underlie results in a publication